Buscar
01/06/2026
From reserve to the full spectrum of flow quantification in risk prediction
Flotats, A. From reserve to the full spectrum of flow quantification in risk prediction. European Heart Journal-Cardiovascular Imaging. 2026; 27(6)DOI:10.1093/ehjci/jeag063. PMID:41758618. IF:6.600(Q1/1D).
01/06/2026
Randomized controlled trials in Europe: a call to action to protect national healthcare systems from the upcoming tsunami of kidney failure
Ortiz, A, Arici, M, Goumenos, DS, Adamczak, M, Eller, K, Ferreira, AC, Grandaliano, G, Jager, KJ, Lees, JS, Liakopoulos, V, Minutolo, R, Sezer, S, Azzolini, L, Fontana, M, Torres, F, Torra, R. Randomized controlled trials in Europe: a call to action to protect national healthcare systems from the upcoming tsunami of kidney failure. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2026; 41(6)DOI:10.1093/ndt/gfag007. PMID:41578941. IF:5.600(Q1/1D).
01/06/2026
Orthostatic blood pressure reduction is associated with renal damage in functionally preserved elderly hypertensive patients
Ramos-Galí, A, de la Sierra, A, Oliveras, A, Armario, P, Ayasreh, N, Arias, P, Vázquez, S, Camps, C, Castellanos, P, Calero, F, Fernández-Llama, P. Orthostatic blood pressure reduction is associated with renal damage in functionally preserved elderly hypertensive patients. NEFROLOGIA. 2026; 46(6)DOI:10.1016/j.nefro.2026.501521. PMID:42225512. IF:2.600(Q2/4D).
01/06/2026
Renal replacement therapies and adherence to EXTRIP consensus criteria in lithium poisoning: the multicenter SILITOX study
Pineda-Torcuato, A, Caballero-Bermejo, AF, Supervia, A, Salgado, E, O'Laoi, R, Sánchez, C, Córdoba, F, Farré, NR, Sanz-López, N, Ontiveros, HH, Sánchez, BAG, Gallardo, PR, Lobo-Antuña, V, Climent, B, Mora, S, Cózar-Llistó, A, Ortiz, MV, Urroz, M, Samper, VM, Román, PN, Suárez, XC, Moro, FJC, Kennedy, C, Jiménez, MDG, Gispert, MAA, Minguez, M, Sanmillán, IL, Cioccari, L, Pérez, BM, Garcia, SV, Gonzalo, JL, Burillo, G, Gutiérrez, E, Nogué-Xarau, S, Puiguriguer-Ferrando, J, Ruiz-Antorán, B. Renal replacement therapies and adherence to EXTRIP consensus criteria in lithium poisoning: the multicenter SILITOX study. EMERGENCIAS. 2026; 38(3)DOI:10.55633/s3me/040.2026. PMID:42345987. IF:6.300(Q1/1D).
01/06/2026
Analysis of comorbidity in an emergency department using diagnostic coding: The Elixhauser Index
Calvet-Pujol, A, Ris-Romeu, J, Albacar-Ingla, M, Vicente-Diez, F, Navarro-Arranz, P, Puig-Campmany, M. Analysis of comorbidity in an emergency department using diagnostic coding: The Elixhauser Index. EMERGENCIAS. 2026; 38(3)DOI:10.55633/s3me/018.2026. PMID:42345985. IF:6.300(Q1/1D).
01/06/2026
Building the foundations for an international patient-centred outcomes set for psoriasis: A scoping study
Vyvey, E, Soenen, R, Oon, HH, Mburu, S, Awici-Rasmussen, M, Affandi, AM, Gulliver, W, Choon, SE, Torres, T, Fitzgerald, A, Gonzalez-Cantero, A, López-Ferrer, A, Lee, CH, Valenzuela, F, Maul, J, Puig, L, Okuse, M, EL-Komy, M, Foley, P, Vender, R, Boehncke, W, Pohunek, J, Wang, YH, Londoño-García, A, Todd, G, Velasquez-Lopera, M, Lebwohl, M, Lau, E, Schmitt-Egenolf, M, Hilhorst, N, Connell, S, Deprez, E, Van Geel, N, Griffiths, C, van de Kerkhof, P, Lambert, J. Building the foundations for an international patient-centred outcomes set for psoriasis: A scoping study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2026; 40(6)DOI:10.1111/jdv.70313. PMID:41641893. IF:8.000(Q1/1D).
01/06/2026
Diagnostic Modalities and Nodal Staging in High-Risk Cutaneous Squamous Cell Carcinoma
Ferrándiz-Pulido, C, Gómez-Tomás, A, Siurana, S, Tortajada, C, Salido-Vallejo, R, Aguayo-Ortiz, RS, Amorós, IR, Turrión-Merino, L, Alvarez, BB, González, IP, Martí-Marti, I, Medrano-Martorell, S, Podlipnik, S, Mollet, J, Masferrer, E, Lopez-Castillo, D, Yébenes, M, Corbacho-Monné, M, Leal, L, Solano-López, A, Ruiz-Salas, V, Granell-Moreno, E, Alfonso, S, Mendoza, MD, Martínez-Domenech, A, Juárez-Dobjanschi, C, González, ES, Díaz, P, Toll, A. Diagnostic Modalities and Nodal Staging in High-Risk Cutaneous Squamous Cell Carcinoma. JAMA Dermatology. 2026; 162(6)DOI:10.1001/jamadermatol.2026.0803. PMID:42018290. IF:11.000(Q1/1D).
01/06/2026
Real-World Use of Baricitinib in Patients with Atopic Dermatitis in Spain: DAMA-S Study, A Retrospective Chart Review
de la Fuente, EG, Herrera, E, Esquerdo, IME, Sarró, DV, Figueras-Nart, I, Salvador, JFS, Gilaberte, Y, Alarcón, SS, Serra-Baldrich, E, Campos, MM, Moro, RM, Díaz-Cerezo, S, Moyano, S, Talavera-Rodríguez, I, Núñez, M. Real-World Use of Baricitinib in Patients with Atopic Dermatitis in Spain: DAMA-S Study, A Retrospective Chart Review. Dermatology and Therapy. 2026; 16(6)DOI:10.1007/s13555-026-01737-7. PMID:42014530. IF:4.200(Q1/1D).